Cargando…
Similarities and Differences Between COVID-19-Related Multisystem Inflammatory Syndrome in Children and Kawasaki Disease
In December 2019, the first case of coronavirus disease (COVID-19) was first reported in Wuhan, China. As of March 2021, there were more than 120 million confirmed cases of COVID-19 and 2.7 million deaths. The COVID-19 mortality rate in adults is around 1–5%, and only a small proportion of children...
Autores principales: | Lee, Min-Sheng, Liu, Yi-Ching, Tsai, Ching-Chung, Hsu, Jong-Hau, Wu, Jiunn-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249705/ https://www.ncbi.nlm.nih.gov/pubmed/34222140 http://dx.doi.org/10.3389/fped.2021.640118 |
Ejemplares similares
-
Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
por: Matucci-Cerinic, Caterina, et al.
Publicado: (2021) -
Kawasaki Disease Shock Syndrome in Japan and Comparison With Multisystem Inflammatory Syndrome in Children in European countries
por: Suzuki, Junko, et al.
Publicado: (2021) -
Global Myocardial Strain in Multisystem Inflammatory Syndrome in Children, Kawasaki Disease, and Healthy Children: A Network Meta-Analysis
por: Liu, Kaiwei, et al.
Publicado: (2022) -
Case report: Multisystem inflammatory syndrome in children associated with COVID-19, macrophage activation syndrome, and incomplete Kawasaki disease
por: Martínez-García, Jesús Javier, et al.
Publicado: (2023) -
Neurological manifestations of Kawasaki disease and multisystem inflammatory syndrome in children associated with COVID-19: A comparison of two different clinical entities
por: Mauro, A., et al.
Publicado: (2023)